US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 5.610
  • +0.610+12.20%
Close Dec 20 16:00 ET
  • 5.540
  • -0.070-1.25%
Post 20:01 ET
343.18MMarket Cap-1.01P/E (TTM)

Sage Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
39.38%-82.37M
38.84%-80.44M
75.38%-37.83M
-17.51%-540.59M
5.84%-119.52M
-14.30%-135.87M
-23.56%-131.52M
-42.56%-153.68M
-21.64%-460.04M
-30.19%-126.93M
Net income from continuing operations
53.60%-93.55M
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.98%-160.33M
-20.30%-146.83M
-16.36%-532.78M
-17.99%-147.15M
Operating gains losses
---51K
-166.67%-112K
20.69%-23K
91.20%-132K
-69.44%-61K
--0
84.15%-42K
97.56%-29K
93.66%-1.5M
99.06%-36K
Depreciation and amortization
-22.73%255K
-6.04%311K
4.02%336K
24.15%1.39M
41.03%409K
18.71%330K
18.64%331K
17.45%323K
-73.17%1.12M
-12.91%290K
Change In working capital
-102.83%-1.18M
-67.06%6.99M
342.40%58.19M
-1,288.22%-67.38M
-1,858.26%-106.29M
954.74%41.69M
719.15%21.22M
-247.07%-24.01M
130.64%5.67M
5.04%6.05M
-Change in receivables
33.61%-4.93M
743.18%566K
5,502.38%72.5M
-1,531.06%-69.35M
-1,363.49%-60.5M
-240.75%-7.42M
97.76%-88K
-3.95%-1.34M
126.19%4.85M
-15.69%4.79M
-Change in prepaid assets
-21.55%9.11M
-117.20%-2.16M
165.27%5.24M
272.97%19M
31.45%2.88M
200.47%11.62M
394.87%12.53M
-404.52%-8.02M
35.46%-10.99M
139.85%2.19M
-Change in payables and accrued expense
-122.04%-8.25M
-23.28%8.92M
-31.31%-19.62M
-210.06%-14.36M
-5,421.87%-48.48M
258.89%37.43M
3.29%11.63M
-92.56%-14.94M
-29.26%13.05M
-114.42%-878K
-Change in other current assets
122.19%4.07M
237.19%1.55M
-2.62%1.93M
-15.07%4.3M
2.28%1.61M
30.06%1.83M
-206.39%-1.13M
96.53%1.99M
17.33%5.06M
66.53%1.58M
-Change in other current liabilities
33.05%-1.18M
-10.24%-1.9M
-10.20%-1.86M
-10.65%-6.97M
-10.35%-1.8M
-10.34%-1.76M
-10.48%-1.72M
-11.50%-1.69M
-9.76%-6.3M
-11.62%-1.63M
Cash from discontinued investing activities
Operating cash flow
39.38%-82.37M
38.84%-80.44M
75.38%-37.83M
-17.51%-540.59M
5.84%-119.52M
-14.30%-135.87M
-23.56%-131.52M
-42.56%-153.68M
-21.64%-460.04M
-30.19%-126.93M
Investing cash flow
Cash flow from continuing investing activities
-49.47%81.05M
-100.85%-386K
-28.45%139.44M
36.10%442.91M
-53.15%42.06M
44.56%160.39M
-66.04%45.59M
2,138.78%194.87M
132.46%325.43M
396.68%89.78M
Net PPE purchase and sale
--0
--0
--0
40.98%-553K
139.72%112K
9.89%-328K
8.20%-112K
-33.14%-225K
-151.88%-937K
24.19%-282K
Net investment purchase and sale
-49.57%81.05M
-100.84%-386K
-28.53%139.44M
35.88%443.47M
-53.42%41.95M
44.38%160.72M
-65.99%45.71M
2,177.88%195.09M
132.57%326.37M
401.31%90.06M
Cash from discontinued investing activities
Investing cash flow
-49.47%81.05M
-100.85%-386K
-28.45%139.44M
36.10%442.91M
-53.15%42.06M
44.56%160.39M
-66.04%45.59M
2,138.78%194.87M
132.46%325.43M
396.68%89.78M
Financing cash flow
Cash flow from continuing financing activities
-62.56%1.04M
852.89%8.07M
-41.73%1.56M
96.32%6.03M
-1,003.45%-262K
125.39%2.77M
6,415.38%847K
48.53%2.67M
-76.98%3.07M
117.06%29K
Net common stock issuance
--1K
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
-48.27%1.44M
-96.96%26K
-52.77%1.56M
122.61%6.93M
--0
122.99%2.77M
2,210.81%855K
83.49%3.3M
-78.85%3.11M
-92.12%33K
Net other financing activities
-9,875.00%-399K
-1,375.00%-118K
99.68%-2K
-2,000.00%-903K
-6,450.00%-262K
73.33%-4K
---8K
---629K
96.90%-43K
99.32%-4K
Cash from discontinued financing activities
Financing cash flow
-62.56%1.04M
852.89%8.07M
-41.73%1.56M
96.32%6.03M
-1,003.45%-262K
125.39%2.77M
6,415.38%847K
48.53%2.67M
-76.98%3.07M
117.06%29K
Net cash flow
Beginning cash position
-16.31%102.73M
-15.56%175.49M
-55.89%72.32M
-44.51%163.97M
-25.39%150.04M
-40.92%122.75M
15.50%207.83M
-44.51%163.97M
-82.23%295.5M
-52.51%201.1M
Current changes in cash
-101.00%-274K
14.49%-72.75M
135.22%103.16M
30.33%-91.65M
-109.34%-77.72M
508.38%27.3M
-405.64%-85.08M
137.95%43.86M
90.38%-131.53M
70.98%-37.13M
End cash Position
-31.71%102.46M
-16.31%102.73M
-15.56%175.49M
-55.89%72.32M
-55.89%72.32M
-25.39%150.04M
-40.92%122.75M
15.50%207.83M
-44.51%163.97M
-44.51%163.97M
Free cash flow
39.52%-82.37M
38.89%-80.44M
75.42%-37.83M
-17.39%-541.14M
6.14%-119.41M
-14.23%-136.19M
-23.53%-131.63M
-42.55%-153.91M
-21.77%-460.97M
-29.98%-127.21M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 39.38%-82.37M38.84%-80.44M75.38%-37.83M-17.51%-540.59M5.84%-119.52M-14.30%-135.87M-23.56%-131.52M-42.56%-153.68M-21.64%-460.04M-30.19%-126.93M
Net income from continuing operations 53.60%-93.55M35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.98%-160.33M-20.30%-146.83M-16.36%-532.78M-17.99%-147.15M
Operating gains losses ---51K-166.67%-112K20.69%-23K91.20%-132K-69.44%-61K--084.15%-42K97.56%-29K93.66%-1.5M99.06%-36K
Depreciation and amortization -22.73%255K-6.04%311K4.02%336K24.15%1.39M41.03%409K18.71%330K18.64%331K17.45%323K-73.17%1.12M-12.91%290K
Change In working capital -102.83%-1.18M-67.06%6.99M342.40%58.19M-1,288.22%-67.38M-1,858.26%-106.29M954.74%41.69M719.15%21.22M-247.07%-24.01M130.64%5.67M5.04%6.05M
-Change in receivables 33.61%-4.93M743.18%566K5,502.38%72.5M-1,531.06%-69.35M-1,363.49%-60.5M-240.75%-7.42M97.76%-88K-3.95%-1.34M126.19%4.85M-15.69%4.79M
-Change in prepaid assets -21.55%9.11M-117.20%-2.16M165.27%5.24M272.97%19M31.45%2.88M200.47%11.62M394.87%12.53M-404.52%-8.02M35.46%-10.99M139.85%2.19M
-Change in payables and accrued expense -122.04%-8.25M-23.28%8.92M-31.31%-19.62M-210.06%-14.36M-5,421.87%-48.48M258.89%37.43M3.29%11.63M-92.56%-14.94M-29.26%13.05M-114.42%-878K
-Change in other current assets 122.19%4.07M237.19%1.55M-2.62%1.93M-15.07%4.3M2.28%1.61M30.06%1.83M-206.39%-1.13M96.53%1.99M17.33%5.06M66.53%1.58M
-Change in other current liabilities 33.05%-1.18M-10.24%-1.9M-10.20%-1.86M-10.65%-6.97M-10.35%-1.8M-10.34%-1.76M-10.48%-1.72M-11.50%-1.69M-9.76%-6.3M-11.62%-1.63M
Cash from discontinued investing activities
Operating cash flow 39.38%-82.37M38.84%-80.44M75.38%-37.83M-17.51%-540.59M5.84%-119.52M-14.30%-135.87M-23.56%-131.52M-42.56%-153.68M-21.64%-460.04M-30.19%-126.93M
Investing cash flow
Cash flow from continuing investing activities -49.47%81.05M-100.85%-386K-28.45%139.44M36.10%442.91M-53.15%42.06M44.56%160.39M-66.04%45.59M2,138.78%194.87M132.46%325.43M396.68%89.78M
Net PPE purchase and sale --0--0--040.98%-553K139.72%112K9.89%-328K8.20%-112K-33.14%-225K-151.88%-937K24.19%-282K
Net investment purchase and sale -49.57%81.05M-100.84%-386K-28.53%139.44M35.88%443.47M-53.42%41.95M44.38%160.72M-65.99%45.71M2,177.88%195.09M132.57%326.37M401.31%90.06M
Cash from discontinued investing activities
Investing cash flow -49.47%81.05M-100.85%-386K-28.45%139.44M36.10%442.91M-53.15%42.06M44.56%160.39M-66.04%45.59M2,138.78%194.87M132.46%325.43M396.68%89.78M
Financing cash flow
Cash flow from continuing financing activities -62.56%1.04M852.89%8.07M-41.73%1.56M96.32%6.03M-1,003.45%-262K125.39%2.77M6,415.38%847K48.53%2.67M-76.98%3.07M117.06%29K
Net common stock issuance --1K------------------0----------------
Proceeds from stock option exercised by employees -48.27%1.44M-96.96%26K-52.77%1.56M122.61%6.93M--0122.99%2.77M2,210.81%855K83.49%3.3M-78.85%3.11M-92.12%33K
Net other financing activities -9,875.00%-399K-1,375.00%-118K99.68%-2K-2,000.00%-903K-6,450.00%-262K73.33%-4K---8K---629K96.90%-43K99.32%-4K
Cash from discontinued financing activities
Financing cash flow -62.56%1.04M852.89%8.07M-41.73%1.56M96.32%6.03M-1,003.45%-262K125.39%2.77M6,415.38%847K48.53%2.67M-76.98%3.07M117.06%29K
Net cash flow
Beginning cash position -16.31%102.73M-15.56%175.49M-55.89%72.32M-44.51%163.97M-25.39%150.04M-40.92%122.75M15.50%207.83M-44.51%163.97M-82.23%295.5M-52.51%201.1M
Current changes in cash -101.00%-274K14.49%-72.75M135.22%103.16M30.33%-91.65M-109.34%-77.72M508.38%27.3M-405.64%-85.08M137.95%43.86M90.38%-131.53M70.98%-37.13M
End cash Position -31.71%102.46M-16.31%102.73M-15.56%175.49M-55.89%72.32M-55.89%72.32M-25.39%150.04M-40.92%122.75M15.50%207.83M-44.51%163.97M-44.51%163.97M
Free cash flow 39.52%-82.37M38.89%-80.44M75.42%-37.83M-17.39%-541.14M6.14%-119.41M-14.23%-136.19M-23.53%-131.63M-42.55%-153.91M-21.77%-460.97M-29.98%-127.21M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.12%